Id |
Subject |
Object |
Predicate |
Lexical cue |
T73 |
0-67 |
Sentence |
denotes |
6 Antiphospholipid antibodies and thrombosis secondary to COVID-19 |
T74 |
68-196 |
Sentence |
denotes |
Deep vein thrombosis, pulmonary embolism and stroke have been observed in patients affected by severe forms of COVID-19 [40,41]. |
T75 |
197-288 |
Sentence |
denotes |
These vascular events, particularly strokes, were mostly recorded in elderly patients [41]. |
T76 |
289-379 |
Sentence |
denotes |
However, 5 cases of stroke were recently reported in relatively young patients (age range: |
T77 |
380-485 |
Sentence |
denotes |
33–49 years), in association with prolonged activated partial-thromboplastin time (aPTT) in 2 cases [42]. |
T78 |
486-749 |
Sentence |
denotes |
Vascular manifestations of COVID-19 comprise either venous or arterial thrombosis or stroke in subjects under the age of 50, sometimes with a severe phenotype that can resemble the “catastrophic” clinical picture associated with antiphospholipid antibodies (aPL). |
T79 |
750-1182 |
Sentence |
denotes |
In patients with systemic autoimmune diseases such as Systemic Lupus Erythematosus (SLE), aPL represent the major cause of thrombosis (either arterial or venous or microangiopathic) and pregnancy morbidity. aPL are pathogenic autoantibodies that can cause the same vascular and obstetric manifestations also in subjects without any other autoimmune disease, suffering from the so called Primary Antiphospholipid Syndrome (APS) [43]. |
T80 |
1183-1423 |
Sentence |
denotes |
The more severe form of APS (the “catastrophic” APS, CAPS) is characterized by a rapidly occurring multiorgan thrombotic damage with histopathological evidence of microangiopathy [44], recalling pictures described in patients with COVID-19. |
T81 |
1424-1532 |
Sentence |
denotes |
CAPS is usually preceded by a precipitating factor, which is an infection in the majority of the cases [45]. |
T82 |
1533-1788 |
Sentence |
denotes |
The link between infection and aPL was first observed when patients with different autoimmune conditions were found to be positive for the serological test of syphilis, whose antigen was described as a mixture of phospholipids, including cardiolipin [46]. |
T83 |
1789-2052 |
Sentence |
denotes |
Nowadays, the detection of aPL is performed by anticardiolipin (aCL) and anti-beta2glicoprotein I (anti-b2GPI) immunoassays and by the functional coagulation test lupus anticoagulant (LA), according to the international consensus APS classification criteria [47]. |
T84 |
2053-2179 |
Sentence |
denotes |
Three cases of COVID-19 patients with severe thrombotic events associated with aCL and anti-b2GPI were recently reported [48]. |
T85 |
2180-2390 |
Sentence |
denotes |
Specifically, aCL of IgA isotype and anti-b2GPI of IgG and IgA isotype were detected, raising the hypothesis that the mucosal damage induced by SARS-CoV-2 could preferentially stimulate the IgA immune response. |
T86 |
2391-2439 |
Sentence |
denotes |
LA was found to be negative in these 3 patients. |
T87 |
2440-2609 |
Sentence |
denotes |
On the other hand, LA was found to be positive in 25 out of 56 (44.6%) consecutive COVID-19 patients, while IgG/IgM aCL and/or anti-b2GPI were positive only in 5 (8.9%). |
T88 |
2610-2681 |
Sentence |
denotes |
No specific relation with thrombosis was mentioned in this cohort [49]. |
T89 |
2682-2799 |
Sentence |
denotes |
In addition, LA was studied in patients with prolonged aPTT, a finding that has been frequently reported in COVID-19. |
T90 |
2800-2926 |
Sentence |
denotes |
More than 90% of patients with prolonged aPTT, with or without clinical evidence of thrombosis, resulted positive for LA [50]. |
T91 |
2927-3043 |
Sentence |
denotes |
Another study investigated patients with acute respiratory distress syndrome and COVID-19 from intensive care units. |
T92 |
3044-3235 |
Sentence |
denotes |
In this study, 50 out of 59 (84.7%) tested patients had LA positive, strongly associated with high D-dimers and thrombosis, particularly if the test was performed early in the disease course. |
T93 |
3236-3305 |
Sentence |
denotes |
In this series only one patient had positive aCL of IgM isotype [51]. |
T94 |
3306-3405 |
Sentence |
denotes |
Therefore, we can assume that aPL can be frequently detected in patients with SARS-CoV-2 infection. |
T95 |
3406-3453 |
Sentence |
denotes |
Certainly, this finding is not surprising [52]. |
T96 |
3454-3720 |
Sentence |
denotes |
In fact, the occurrence of transient aPL was described in patients affected by several viral infections such as human immunodeficiency virus (HIV), varicella zoster, hepatitis C virus, cytomegalovirus (CMV), Epstein–Barr virus (EBV), adenovirus, parvovirus B19 [53]. |
T97 |
3721-3912 |
Sentence |
denotes |
In addition, aPL were also detected in patients with infections of different origin (bacterial, parasitic, etc) and an infection was often reported just before the clinical onset of APS [54]. |
T98 |
3913-4151 |
Sentence |
denotes |
These observations suggest the possible existence of molecular mimicry due to similarity between the peptide regions identified in the b2GPI molecule (and recognized by anti-b2GPI) and membrane proteins of several virus and bacteria [55]. |
T99 |
4152-4343 |
Sentence |
denotes |
Animals immunized with different viruses or bacteria (or proteins derived from them) developed anti-b2GPI antibodies that in some cases were associated with the occurrence of thrombosis [56]. |
T100 |
4344-4496 |
Sentence |
denotes |
The different pathogenic potential of antibodies can be attributed to the fine specificity that they acquire after immunization with different antigens. |
T101 |
4497-4788 |
Sentence |
denotes |
It is in fact known that antibodies directed to domain 1 of the b2GPI molecule are associated with an increased risk of thrombosis (in systemic autoimmune diseases and APS) [57] while antibodies directed to other parts of the molecule, such as domain 4/5, can be regarded as “innocent” [58]. |
T102 |
4789-5055 |
Sentence |
denotes |
On the other hand, the features of the host can also be important, since genetic background is recognized as one of the determinant factors in the induction of autoimmunity and can be the driver which turns aPL from being transient to persistent and pathogenic [59]. |
T103 |
5056-5236 |
Sentence |
denotes |
The above considerations widely justify why aPL, detected with different assays, can be found in patients affected by COVID-19, sometimes associated with thrombosis but not always. |
T104 |
5237-5477 |
Sentence |
denotes |
To our knowledge, no increased rate of miscarriages or fetal loss have been reported during SARS-CoV-2 pandemic so far, although some severe pregnancy complication, like those linked to aPL, such as HELLP syndrome were occasionally seen (A. |
T105 |
5478-5512 |
Sentence |
denotes |
Lojacono, personal communication). |
T106 |
5513-5684 |
Sentence |
denotes |
Whether pregnant women with COVID-19 have an increased rate of positive aPL during pregnancy is not known yet nor it is defined their possible impact on pregnancy outcome. |
T107 |
5685-5724 |
Sentence |
denotes |
COVID-19 is a novel infectious disease. |
T108 |
5725-5810 |
Sentence |
denotes |
The true relationship between this infection and aPL need to be further investigated. |
T109 |
5811-6018 |
Sentence |
denotes |
However, according to the “second hit hypothesis” [60], the thrombogenic potential of aPL is magnified in the presence of an infection or a severe inflammatory state, which is often associated with COVID-19. |
T110 |
6019-6245 |
Sentence |
denotes |
Therefore, the search for aPL may be considered in the management of COVID-19 patients with vascular manifestations, as the detection of positive aPL would allow of the indication for an early adequate anticoagulant treatment. |
T111 |
6246-6436 |
Sentence |
denotes |
In the case of aPL positivity, a follow-up testing after at least 12 weeks is warranted, in order to verify the persistence of aPL, which would suggest the post-infectious occurrence of APS. |
T112 |
6437-6656 |
Sentence |
denotes |
In fact, APS is currently considered as a systemic autoimmune disease which is not limited to thrombosis and pregnancy morbidity and deserves specific long-term management including anticoagulation and immunomodulation. |